Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience

• Li-Ching Lin,
• Wen-Kuan Huang,
• Chueh-Chuan Yen,
• Chueh-Chuan Yen,
• Ching-Yao Yang,
• Meng-Ta Sung,
• Natalie S.M. Wong,
• Daniel T. T. Chua,
• Sarah W. M. Lee,
• Jen-Shi Chen,
• Chun-Nan Yeh

Affiliations

Li-Ching Lin

Department of Surgery and GIST Team, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan

Wen-Kuan Huang

Division of Hematology-Oncology, Department of Internal Medicine and GIST Team, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan

Chueh-Chuan Yen

Division of Clinical Research, Department of Medical Research and Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan

Chueh-Chuan Yen

National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan

Ching-Yao Yang

Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan

Meng-Ta Sung

Department of Oncology, Mennonite Christian Hospital, Haulien, Taiwan

Natalie S.M. Wong

Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, Hong Kong SAR, China

Daniel T. T. Chua

Department of Medicine, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong SAR, China

Sarah W. M. Lee

Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong SAR, China

Jen-Shi Chen

Division of Hematology-Oncology, Department of Internal Medicine and GIST Team, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan

Chun-Nan Yeh

Department of Surgery and GIST Team, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan